Cargando…

Matrix Metalloproteases in Pancreatic Ductal Adenocarcinoma: Key Drivers of Disease Progression?

Pancreatic cancer is a dismal disorder that is histologically characterized by a dense fibrotic stroma around the tumor cells. As the extracellular matrix comprises the bulk of the stroma, matrix degrading proteases may play an important role in pancreatic cancer. It has been suggested that matrix m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Slapak, Etienne J., Duitman, JanWillem, Tekin, Cansu, Bijlsma, Maarten F., Spek, C. Arnold
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235986/ https://www.ncbi.nlm.nih.gov/pubmed/32325664 http://dx.doi.org/10.3390/biology9040080

Ejemplares similares

Protease‐activated receptor 1 drives and maintains ductal cell fates in the premalignant pancreas and ductal adenocarcinoma
por: Tekin, Cansu, et al.
Publicado: (2021)

Non-Tumor CCAAT/Enhancer-Binding Protein Delta Potentiates Tumor Cell Extravasation and Pancreatic Cancer Metastasis Formation
por: Duitman, JanWillem, et al.
Publicado: (2021)

Mesoporous Silica Nanoparticle-Based Drug Delivery Systems for the Treatment of Pancreatic Cancer: A Systematic Literature Overview
por: Slapak, Etienne J., et al.
Publicado: (2022)

Macrophage C/EBPδ Drives Gemcitabine, but Not 5-FU or Paclitaxel, Resistance of Pancreatic Cancer Cells in a Deoxycytidine-Dependent Manner
por: Spek, C. Arnold, et al.
Publicado: (2022)

Is idiopathic pulmonary fibrosis a cancer-like disease? Transcriptome analysis to fuel the debate
por: Spek, C. Arnold, et al.
Publicado: (2019)

PCSK6: The Endogenous PAR-1 Agonist Driving Pulmonary Fibrosis?
por: Spek, C. Arnold, et al.
Publicado: (2023)

Early macrophage infiltrates impair pancreatic cancer cell growth by TNF-α secretion
por: Tekin, Cansu, et al.
Publicado: (2020)

C/EBP-Family Redundancy Determines Patient Survival and Lymph Node Involvement in PDAC
por: Hartl, Leonie, et al.
Publicado: (2023)

Plasmin reduces fibronectin deposition by mesangial cells in a protease-activated receptor-1 independent manner
por: Waasdorp, Maaike, et al.
Publicado: (2017)

Preclinical Assessment of ADAM9-Responsive Mesoporous Silica Nanoparticles for the Treatment of Pancreatic Cancer
por: Slapak, Etienne J., et al.
Publicado: (2023)

CCAAT/Enhancer-Binding Protein Delta (C/EBPδ): A Previously Unrecognized Tumor Suppressor that Limits the Oncogenic Potential of Pancreatic Ductal Adenocarcinoma Cells
por: Hartl, Leonie, et al.
Publicado: (2020)

ADAM9-Responsive Mesoporous Silica Nanoparticles for Targeted Drug Delivery in Pancreatic Cancer
por: Slapak, Etienne J., et al.
Publicado: (2021)

The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma
por: Houg, Demi S., et al.
Publicado: (2018)

Protease-activated receptor-1 deficiency protects against streptozotocin-induced diabetic nephropathy in mice
por: Waasdorp, Maaike, et al.
Publicado: (2016)

Vorapaxar treatment reduces mesangial expansion in streptozotocin-induced diabetic nephropathy in mice
por: Waasdorp, Maaike, et al.
Publicado: (2018)

Immune Checkpoints as Promising Targets for the Treatment of Idiopathic Pulmonary Fibrosis?
por: Duitman, JanWillem, et al.
Publicado: (2019)

Editorial: Translational Insights Into Pancreatic Ductal Adenocarcinoma
por: Bijlsma, Maarten F., et al.
Publicado: (2022)

PAR1 signaling on tumor cells limits tumor growth by maintaining a mesenchymal phenotype in pancreatic cancer
por: Tekin, Cansu, et al.
Publicado: (2018)

C/EBPδ Suppresses Motility-Associated Gene Signatures and Reduces PDAC Cell Migration
por: Hartl, Leonie, et al.
Publicado: (2022)

Protease‐activated receptor‐1 contributes to renal injury and interstitial fibrosis during chronic obstructive nephropathy
por: Waasdorp, Maaike, et al.
Publicado: (2018)

Clinical study of genomic drivers in pancreatic ductal adenocarcinoma
por: Barrett, Michael T, et al.
Publicado: (2017)

Myeloid DNA methyltransferase3b deficiency aggravates pulmonary fibrosis by enhancing profibrotic macrophage activation
por: Qin, Wanhai, et al.
Publicado: (2022)

Macrophage-secreted MMP9 induces mesenchymal transition in pancreatic cancer cells via PAR1 activation
por: Tekin, Cansu, et al.
Publicado: (2020)

CEBPD Potentiates the Macrophage Inflammatory Response but CEBPD Knock-Out Macrophages Fail to Identify CEBPD-Dependent Pro-Inflammatory Transcriptional Programs
por: Spek, C. Arnold, et al.
Publicado: (2021)

Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma
por: Gao, He-Li, et al.
Publicado: (2020)

Key drug-targeting genes in pancreatic ductal adenocarcinoma
por: Sakharkar, Meena Kishore, et al.
Publicado: (2021)

High‐grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF‐1
por: Steins, Anne, et al.
Publicado: (2020)

RNA Binding Proteins as Drivers and Therapeutic Target Candidates in Pancreatic Ductal Adenocarcinoma
por: Glaß, Markus, et al.
Publicado: (2020)

Detrimental role for CCAAT/enhancer binding protein δ in blood-borne brain infection
por: Duitman, JanWillem, et al.
Publicado: (2016)

CCAAT/enhancer binding protein delta (C/EBPδ) deficiency does not affect bleomycin-induced pulmonary fibrosis
por: JanWillem, Duitman, et al.
Publicado: (2018)

An Immunological Glance on Pancreatic Ductal Adenocarcinoma
por: Melzer, Michael Karl, et al.
Publicado: (2020)

Physiology and pathophysiology of matrix metalloproteases
por: Klein, T., et al.
Publicado: (2010)

Monocarboxylate Transporters Are Involved in Extracellular Matrix Remodelling in Pancreatic Ductal Adenocarcinoma
por: Ufuk, Ayşe, et al.
Publicado: (2022)

Prognostic significance of plasma matrix metalloprotease-2 in pancreatic cancer patients
por: Singh, Nidhi, et al.
Publicado: (2017)

Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma
por: Buscail, Etienne, et al.
Publicado: (2019)

Soluble Compounds Released by Hypoxic Stroma Confer Invasive Properties to Pancreatic Ductal Adenocarcinoma
por: Liu, Dajia, et al.
Publicado: (2020)

Expressions of Matrix Metalloproteinases 2, 7, and 9 in Carcinogenesis of Pancreatic Ductal Adenocarcinoma
por: Jakubowska, Katarzyna, et al.
Publicado: (2016)

Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins
por: Liot, Sophie, et al.
Publicado: (2021)

Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance
por: Palamaris, Kostas, et al.
Publicado: (2021)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ej5aj0hudnj3pl9qorur1pnqp9